Heart rate reduction with ivabradine prevents thyroid hormone-induced cardiac remodeling in rat

Heart and Vessels

Volumn 28, Issue 4, 2013, Pages 524-535

  Kim, Bo Hyun ^a,d   Cho, Kyoung Im ^e   Kim, Seong Man ^b   Kim, Nari ^c   Han, Jin ^c   Kim, Jee Yeon ^a   Kim, In Ju ^a,d  

^a Pusan National University School of Medicine   (South Korea)

^b Maryknoll Hospital   (South Korea)

^c Inje University   (South Korea)

^d Pusan National University   (South Korea)

^e Kosin University   (South Korea)

Author keywords

Echocardiography; Electrophysiology; Heart failure; Thyroid hormone

Indexed keywords

ION CHANNEL; IVABRADINE; LEVOTHYROXINE; THORIUM; THYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CARDIAC REMODELING; CELL SIZE; CONTROLLED STUDY; DRUG MECHANISM; ECHOCARDIOGRAPHY; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART RATE; INOTROPISM; ION CURRENT; MALE; MORPHOLOGY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RANDOMIZATION; RAT; SINUS NODE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BENZAZEPINES; CALCIUM SIGNALING; DISEASE MODELS, ANIMAL; FIBROSIS; HEART RATE; HEART VENTRICLES; HYPERTHYROIDISM; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; STROKE VOLUME; THYROXINE; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84880295347     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-012-0304-z     Document Type: Article

References (43)

1. Biondi B, Palmieri EA, Lombardi G, Fazio S (2002) Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 87:968-974
2. Klein I, Ojamaa K (2001) Thyroid hormone and the cardiovascular system. N Engl J Med 344:501-509
3. Khandwala HM (2004) A case of congestive heart failure due to reversible dilated cardiomyopathy caused by hyperthyroidism. South Med J 97:1001-1003
4. Kim JY, Kim BS, Kang JH (2001) Dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease. Int J Cardiol 80:101-103
5. Riaz K, Forker AD, Isley WL, Hamburg MS, McCullough PA (2003) Hyperthyroidism: a "curable" cause of congestive heart failure-three case reports and a review of the literature. Congest Heart Fail 9:40-46
6. Watanabe E, Ohsawa H, Noike H, Okamoto K, Tokuyama A, Kanai M, Mineoka K, Miyashita Y, Kantoh S, Hiruta N (1995) Dilated cardiomyopathy associated with hyperthyroidism. Intern Med 34:762-767
7. Yu YH, Bilezikian JP (2000) Tachycardia-induced cardiomyopathy secondary to thyrotoxicosis: a young man with previously unrecognized Graves' disease. Thyroid 10:923-927
8. Degens H, Gilde AJ, Lindhout M, Willemsen PH, Van Der Vusse GJ, Van Bilsen M (2003) Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment. Am J Physiol Heart Circ Physiol 284:H108-H115
9. Cacciatori V, Bellavere F, Pezzarossa A, Dellera A, Gemma ML, Thomaseth K, Castello R, Moghetti P, Muggeo M (1996) Power spectral analysis of heart rate in hyperthyroidism. J Clin Endocrinol Metab 81:2828-2835
10. von Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R, Beyer J, Meyer J (1989) Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 63:930-933
11. Sun ZQ, Ojamaa K, Nakamura TY, Artman M, Klein I, Coetzee WA (2001) Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol 33:811-824
12. Yanagihara K, Irisawa H (1980) Inward current activated during hyperpolarization in the rabbit sinoatrial node cell. Pflugers Arch 385:11-19
13. Brown HF, DiFrancesco D, Noble SJ (1979) How does adrenaline accelerate the heart? Nature 280:235-236
14. Thollon C, Cambarrat C, Vian J, Prost JF, Peglion JL, Vilaine JP (1994) Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol 112:37-42
15. f inhibition with ivabradine: electrophysiological effects and safety. Drug Saf 31:95-107
16. Becker M, Bilke E, Kuhl H, Katoh M, Kramann R, Franke A, Bucker A, Hanrath P, Hoffmann R (2006) Analysis of myocardial deformation based on pixel tracking in two-dimensional echocardiographic images enables quantitative assessment of regional left ventricular function. Heart 92:1102-1108
17. Thomas JD, Popovic ZB (2006) Assessment of left ventricular function by cardiac ultrasound. J Am Coll Cardiol 48:2012-2025
18. Cohen MV, Schulman IC, Spenillo A, Surks MI (1981) Effects of thyroid hormone on left ventricular function in patients treated for thyrotoxicosis. Am J Cardiol 48:33-38
19. Friedman MJ, Okada RD, Ewy GA, Hellman DJ (1982) Left ventricular systolic and diastolic function in hyperthyroidism. Am Heart J 104:1303-1308
20. Forfar JC, Matthews DM, Toft AD (1984) Delayed recovery of left ventricular function after antithyroid treatment. Further evidence for reversible abnormalities of contractility in hyperthyroidism. Br Heart J 52:215-222
21. Feldman T, Borow KM, Sarne DH, Neumann A, Lang RM (1986) Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 7:967-974
22. McKinsey TA, Olson EN (2005) Toward transcriptional therapies for the failing heart: chemical screens to modulate genes. J Clin Invest 115:538-546
23. Weber KT (2000) Fibrosis and hypertensive heart disease. Curr Opin Cardiol 15:264-272
24. Sernia C, Marchant C, Brown L, Hoey A (1993) Cardiac angiotensin receptors in experimental hyperthyroidism in dogs. Cardiovasc Res 27:423-428
25. Kobori H, Ichihara A, Suzuki H, Miyashita Y, Hayashi M, Saruta T (1997) Thyroid hormone stimulates renin synthesis in rats without involving the sympathetic nervous system. Am J Physiol 272:E227-E232
26. Sandow A (1952) Excitation-contraction coupling in muscular response. Yale J Biol Med 25:176-201
27. Uehara Y, Azuma Y, Minai K, Yoshida H, Yoshimura M, Shimizu M (2012) Endothelin-1 prolongs intracellular calcium transient decay in neonatal rat cardiac myocytes. Heart Vessels 27:98-105
28. Brooksby P, Levi AJ, Jones JV (1993) The electrophysiological characteristics of hypertrophied ventricular myocytes from the spontaneously hypertensive rat. J Hypertens 11:611-622
29. Keung EC (1989) Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium. Circ Res 64:753-763
30. Scamps F, Mayoux E, Charlemagne D, Vassort G (1990) Calcium current in single cells isolated from normal and hypertrophied rat heart. Effects of beta-adrenergic stimulation. Circ Res 67:199-208
31. Gomez AM, Benitah JP, Henzel D, Vinet A, Lorente P, Delgado C (1997) Modulation of electrical heterogeneity by compensated hypertrophy in rat left ventricle. Am J Physiol 272:H1078-H1086
32. Xiao YF, McArdle JJ (1994) Elevated density and altered pharmacologic properties of myocardial calcium current of the spontaneously hypertensive rat. J Hypertens 12:783-790
33. Kreuzberg, Theissen P, Schicha H, Schroder F, Mehlhorn U, de Vivie ER, Boknik P, Neumann J, Grohe C, Herzig S (2000) Single-channel activity and expression of atrial L-type Ca channels in patients with latent hyperthyroidism. Am J Physiol 278:H723-H730
34. 2+ current in guinea pig ventricular myocytes. Pflugers Arch 421:425-430
35. Watanabe H, Ma M, Washizuka T, Komura S, Yoshida T, Hosaka Y, Hatada K, Chinushi M, Yamamoto T, Watanabe K, Aizawa Y (2003) Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biophys Res Commun 308:439-444
36. Kashimura T, Kodama M, Tanaka K, Sonoda K, Watanabe S, Ohno Y, Tomita M, Obata H, Mitsuma W, Ito M, Hirono S, Hanawa H, Aizawa Y (2012) Mechanical alternans in human idiopathic dilated cardiomyopathy is caused with impaired force-frequency relationship and enhanced poststimulation potentiation. Heart Vessels. doi: 10.1007/s00380-012-0251-8
37. Yu H, Chang F, Cohen IS (1993) Pacemaker current exists in ventricular myocytes. Circ Res 72:232-236
38. Ranjan R, Chiamvimonvat N, Thakor NV, Tomaselli GF, Marban E (1998) Mechanism of anode break stimulation in the heart. Biophys J 74:1850-1863
39. Cerbai E, Pino R, Porciatti F, Sani G, Toscano M, Maccherini M, Giunti G, Mugelli A (1997) Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes from human failing heart. Circulation 95:568-571
40. Hoppe UC, Jansen E, Sudkamp M, Beuckelmann DJ (1998) Hyperpolarization- activated inward current in ventricular myocytes from normal and failing human hearts. Circulation 97:55-65
41. f in ventricular myocytes from normotensive and hypertensive rats during aging. Circulation 94:1674-1681
42. Ceconi C, Comini L, Suffredini S, Stillitano F, Bouly M, Cerbai E, Mugelli A, Ferrari R (2011) Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. Am J Physiol Heart Circ Physiol 300:366-373
43. Suffredini S, Stillitano F, Comini L, Bouly M, Brogioni S, Ceconi C, Ferrari R, Mugelli A, Cerbai E (2012) Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression. Br J Pharmacol 165:1457-1466